Hyris is an innovation-based, fast-growing biotech company founded in 2014, headquartered in the United Kingdom. The company's slogan, "Hyris is an innovation-based, fast-growing biotech Company, which aims to democratize genetic analysis", encapsulates its visionary mission. Hyris is dedicated to democratizing genetic analysis by providing its partners and clients with a disruptive System that allows genetic testing of biological samples in any setting, at any time. The company's commitment to facilitating diagnostic and genetic analysis even under the harshest conditions makes it a standout player in the Biotechnology and Life Sciences industries.
Hyris' recent growth has captured attention, particularly with its €2.50M Series A investment on 27 May 2020. This investment was made by Astanor Ventures and Pi Campus, indicating notable confidence from established investors.